OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Proteomics and Drug Repurposing in CLL towards Precision Medicine
Dimitra Mavridou, Konstantina Psatha, Michalis Aivaliotis
Cancers (2021) Vol. 13, Iss. 14, pp. 3391-3391
Open Access | Times Cited: 8
Dimitra Mavridou, Konstantina Psatha, Michalis Aivaliotis
Cancers (2021) Vol. 13, Iss. 14, pp. 3391-3391
Open Access | Times Cited: 8
Showing 8 citing articles:
Multiple omics levels of chronic lymphocytic leukemia
Aleksander Turk, Eva Čeh, George A. Călin, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Aleksander Turk, Eva Čeh, George A. Călin, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Drug Repurposing in Cancer Therapy
Srijita Sen, H. S. Kushwah, Om Prakash Ranjan
Drug repurposing (2024), pp. 57-92
Closed Access | Times Cited: 5
Srijita Sen, H. S. Kushwah, Om Prakash Ranjan
Drug repurposing (2024), pp. 57-92
Closed Access | Times Cited: 5
SYT7 regulates the progression of chronic lymphocytic leukemia through interacting and regulating KNTC1
Wenjie Zhang, Jinlan Long, Peixia Tang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Wenjie Zhang, Jinlan Long, Peixia Tang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Unlocking the potential of signature-based drug repurposing for anticancer drug discovery
Sruti Biswal, Bibekanand Mallick
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110150-110150
Closed Access | Times Cited: 2
Sruti Biswal, Bibekanand Mallick
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110150-110150
Closed Access | Times Cited: 2
The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine
Isacco Ferrarini, Antonella Rigo, Carlo Visco
Haematologica (2022) Vol. 107, Iss. 4, pp. 790-802
Open Access | Times Cited: 10
Isacco Ferrarini, Antonella Rigo, Carlo Visco
Haematologica (2022) Vol. 107, Iss. 4, pp. 790-802
Open Access | Times Cited: 10
Personalized redox biology: Designs and concepts
Nikos V. Margaritelis
Free Radical Biology and Medicine (2023) Vol. 208, pp. 112-125
Closed Access | Times Cited: 6
Nikos V. Margaritelis
Free Radical Biology and Medicine (2023) Vol. 208, pp. 112-125
Closed Access | Times Cited: 6
Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia
Dimitra Mavridou, Konstantina Psatha, Michalis Aivaliotis
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 831-831
Open Access
Dimitra Mavridou, Konstantina Psatha, Michalis Aivaliotis
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 831-831
Open Access
Bcl-2 Inhibition Induces a Synergistic Effect in Combination with Doxorubicin in Chronic Lymphocytic Leukemia
Mohammad Sadeghi, Koosha Sepasi, Amir Honarmand Alamdari, et al.
ImmunoAnalysis (2022) Vol. 2, pp. 14-14
Open Access
Mohammad Sadeghi, Koosha Sepasi, Amir Honarmand Alamdari, et al.
ImmunoAnalysis (2022) Vol. 2, pp. 14-14
Open Access
